The accurate assessment of individual risk can be of great value to guiding and facilitating the prevention of atherosclerotic cardiovascular disease (ASCVD). However, prediction models in common use were formulated primarily in white populations. The China-PAR project (Prediction for ASCVD Risk in China) is aimed at developing and validating 10-year risk prediction equations for ASCVD from 4 contemporary Chinese cohorts.
Rapidly increasing per-capita income, an aging population, westernization of lifestyle, and longer life spans led to dramatic changes in the CVD risk factors pattern in China during the past decade. 13 The disease burdens of CHD and stroke also increased and contributed to the major challenge of primary care in China. 4 Although Chinese risk prediction tools for CHD and ischemic CVD were developed 10 years ago and were based on Framingham equations, 14, 15 data based on a large sample size of Chinese adults were limited for risk prediction models that focused on all ASCVD, defined as nonfatal acute MI or CHD death or fatal or nonfatal stroke. Therefore, we conducted the China-PAR project (Prediction for AS-CVD Risk in China) to develop and validate the Chinese ASCVD risk equations in multiple contemporary Chinese cohorts with a total of 106 281 participants.
MethODs

Derivation cohort
The China-PAR project used InterASIA (International Collaborative Study of Cardiovascular Disease in Asia) and China MUCA (1998) (China Multi-Center Collaborative Study of Cardiovascular Epidemiology) to develop the Chinese ASCVD risk equations as the derivation cohort. InterASIA, which was established from 2000 to 2001, selected a nationally representative sample 35 to 74 years of age in China using a 4-stage stratified sampling method. The sampling process was stratified by geographic region (northern/southern China, divided by the Yangtzi River) and urbanization (urban/rural); detailed information has been published elsewhere. 16 The China MUCA (1998) was established in 1998 with cluster random sampling. Fifteen clusters were selected that also were based on geographic region and urbanization, with ≈500 men and 500 women 35 to 59 years of age in each cluster. 17 Among the 27 020 participants from these 2 studies, 24 334 (90.1%) completed the follow-up survey with an average follow-up duration of 12.3 years. After the exclusion of 418 participants with MI or stroke, 1094 participants with poorquality measurements for blood specimens at baseline, and 1502 participants who were followed up only until 2008 and did not participate in the second follow-up survey from 2012 to 2015, we included 21 320 participants to derive the China-PAR equations ( Figure I in the online-only Data Supplement).
Baseline examination was conducted by trained research staff under stringent quality control in both studies. Demographics, lifestyle information, and medical history were collected with standardized questionnaires. Current cigarette smoking was self-reported by participants. Family history of ASCVD was defined as at least a parent or a sibling with MI or stroke. Body weight and height were measured with the subject wearing light indoor clothes without shoes, and body mass index was calculated as kilograms per meters squared. Waist circumference (WC) was measured at 1 cm above the navel at minimal respiration. Three blood pressure (BP) measurements were taken after a 5-minute rest in subjects while seated. The mean of the 3 BPs was used in the analysis. In addition, blood samples were drawn from participants after fasting for at least 10 hours to measure serum glucose and lipids levels. Diabetes
clinical Perspective
What is new?
• The China-PAR project (Prediction for ASCVD Risk in China) is the first study to develop and validate 10-year risk prediction equations for atherosclerotic cardiovascular disease (ASCVD) using data from 4 contemporary Chinese cohorts. • The sex-specific equations had excellent performance of ASCVD risk prediction with good internal consistency and external validation; our findings also indicated that the Pooled Cohort Equations derived from Western populations were not appropriate for the Chinese population.
What are the clinical implications?
• Risk assessment is a fundamental component of prevention of ASCVD. • More aggressive risk factor modification should be required among individuals with a predicted high risk. • The sex-specific China-PAR equations provide a valuable tool for identifying high-risk individuals and matching the intensity of preventive interventions to an individual's absolute risk of ASCVD development. • The risk prediction equations will help clinicians guide preventive approaches, individualized counseling, and treatment decisions for ASCVD by more accurate estimation of 10-year risk of ASCVD.
mellitus was defined as having a fasting glucose ≥126 mg/dL or self-reported current treatment with antidiabetes medication (insulin or oral hypoglycemic agents). The first follow-up survey for both InterASIA and the China MUCA (1998) was conducted during 2007 to 2008, and the second was conducted during 2012 to 2015. Study participants or their proxies were identified and interviewed to obtain disease status and vital information. Hospital records or death certificates were also collected. A study-wide end-point assessment committee at Fuwai Hospital in Beijing adjudicated the final end-point events by reviewing all incidence and death records. Two committee members independently verified the events, and discrepancies were resolved by discussion involving additional committee members.
ASCVD was defined as nonfatal acute MI or CHD death or fatal or nonfatal stroke. Acute MI was identified as a change in biochemical markers of myocardial necrosis accompanied by ischemic symptoms, pathological Q waves, ST-segment elevation or depression, or coronary intervention. 18 CHD death included all fatal events resulting from MI or other coronary deaths. Stroke included clinical signs and symptoms of subarachnoid or intracerebral hemorrhage or cerebral infarction, which were rapidly developing signs of focal (or global) disturbances in cerebral function lasting >24 hours without an apparent nonvascular cause. The CIMIC was a large, community-based cohort that was established from 2007 to 2008. The study selected 4 survey sites from 3 provinces (Shandong, Henan, and Jiangsu) with different economic development levels in China. Two communities in rural areas were selected from each survey site. Approximately 10 000 participants were selected randomly in each community. In total, 86 428 participants ≥16 years of age completed the baseline study and were invited to participate in the follow-up survey from 2012 to 2015. The methods for the baseline and follow-up surveys were the same as for InterASIA. In total, 80 929 participants (93.6%) were followed up successfully, with an average follow-up duration of 5.9 years. Data from a 70 838 participants 35 to 74 years of age who were free of MI and stroke at baseline were used for external validation ( Figure I in the online-only Data Supplement).
Validation cohort
These preceding studies were all approved by the Institutional Review Board at Fuwai Hospital in Beijing. Written informed consent was obtained from each participant before data collection.
statistical analysis
Sex-specific means or corresponding percentages of baseline variables were calculated. Person-years of follow-up for each study participant were calculated as the difference between the date of the baseline examination and the date of occurrence of ASCVD, the date of death, or the last follow-up interview, whichever occurred first.
Ten-year ASCVD risk was defined as the risk of developing the first ASCVD event over a 10-year period among a population without ASCVD at baseline. The ASCVD risk prediction equations were developed from sex-specific Cox proportional hazards models. All continuous covariates in the models were natural log-transformed to improve the discrimination and calibration of the prediction models and to minimize the influence of extreme observations. The major risk factors were retained in our models directly, including age, treated or untreated systolic BP (SBP), total cholesterol, HDL-C, current smoking (yes/ no), and diabetes mellitus (yes/no). In addition, we evaluated whether the model would be improved by the inclusion of additional variables, including body mass index, WC, geographic region (northern/southern China), urbanization (urban/rural), and family history of ASCVD (yes/no). The final models should include variables with a relative integrated discrimination improvement (IDI) index of ≥6%. 10 Interactions with age were also considered for each risk factor. The final models should include any interaction terms with value of P<0.01 or P=0.01 to 0.05 and the continuous net reclassification improvement for nonevents ≥15% or statistically significant IDI. 20, 21 Model fit was evaluated by discrimination C statistics and calibration χ 2 using the modified Nam-D'Agostino test. [22] [23] [24] Internal consistency of the discrimination and calibration performance measures was evaluated by a 10×10 cross-validation technique. 25 Means and percentiles of the discrimination C statistic, calibration χ 2 , and calibration slope in internal validation were calculated and compared with those in the models for the whole population.
We evaluated the performance of the equations in predicting 10-year ASCVD events in the China MUCA (1992-1994) and 5-year ASCVD events in the CIMIC. For the CIMIC, the equations were adjusted for the reduced follow-up time by calculating 5-year baseline survival rate using methods developed by D'Agostino et al. 26 All other parameters were the same as the 10-year prediction equations. We assessed the equations by using predicted number of events, discrimination C statistic, and calibration χ 2 in validation cohorts. We also illustrated the prediction ability of the equations by using calibration charts. Participants in the validation cohorts were divided into 4 categories based on predicted ASCVD risk (<5%, 5%-7.4%, 7.5%-9.9%, and ≥10%), which were clinically meaningful cut points. Kaplan-Meier analysis was used to obtain the observed ASCVD event rate, 23 which was then compared with the predicted event rate in each category in calibration charts. The results were also shown in calibration plots comparing the predicted probabilities with the observed probabilities according to the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis statement. 27 ORIGINAL RESEARCH
The PCEs released in the American College of Cardiology/ American Heart Association guideline were evaluated in the derivation cohort and 2 validation cohorts. We calculated the predicted number of events, discrimination C statistic, and calibration χ 2 to assess the PCEs and made comparisons with those estimates from our equations. We also drew calibration charts in deciles of predicted risk to illustrate the difference of prediction between the PCEs and our equations.
All analyses were conducted with the SAS statistical package (version 9.2; SAS Institute, Inc., Cary, NC).
results
The baseline characteristics and ASCVD event rates of the derivation cohort are presented in Table 1 . Men were slightly older and had a larger WC, higher SBP and diastolic BP, and lower total cholesterol and HDL-C levels than women. Men were more likely to be current smokers and less likely to have had antihypertensive treatment within the previous 2 weeks. During an average follow-up of 12.3 years, 1048 incident ASCVD events (645 in men and 403 in women) were identified, with a higher ASCVD event rate in men than in women after Kaplan-Meier adjustment.
Sex-specific equations were developed from the derivation cohort for assessing 10-year ASCVD risk among a Chinese population. Besides the major risk factors (age, treated or untreated SBP, total cholesterol, HDL-C, current smoking, and diabetes mellitus), 4 additional variables-WC, geographic region, urbanization, and family history of ASCVD (relative IDI=6.9%, 65.4%, 26.1%, and 24.3%, respectively)-were added to the equation for men, and 2 additional variables-WC and geographic region (relative IDI=9.6% and 21.3%, respectively)-were added to the equation for women. Available interaction terms of age with risk factors (treated or untreated SBP, current smoking, and family history of ASCVD) were also added to the equations as covariates. The parameters for the equations are shown in Table I in the online-only Data Supplement with the specification in Table II in the online-only Data Supplement. For example, the 10-year ASCVD risk was estimated for an individual 60 years of age with untreated SBP of 130 mm Hg, total cholesterol of 210 mg/dL, HDL-C of 55 mg/dL, and WC of 80 cm; who did not smoke; who had diabetes mellitus; who lived in an urban area of northern China; and who did not have a family history of ASCVD. According to the equations, the predicted 10-year ASCVD risk was 11.0% for men and 10.1% for women. Given the levels of risk factors that remained, the sex-specific predicted risk of ASCVD increased with aging, which ranged from 2.2% to 19.6% in men and from 2.4% to 17.1% in women ( Table 2) .
Our equations had good discrimination and calibration for ASCVD in both sexes. Women had a numerically higher C statistic than men (0.811 versus 0.794), although the difference is not significant. Calibration χ 2 values were 13.1 for men and 12.8 for women, which indicated excellent goodness of fit for our equations. Internal validation demonstrated that the means of discrimination C statistic, calibration χ 2 , and calibration slope were similar to those from the models for the whole population, which indicated good internal consistency for our equations (Table 3) . ASCVD indicates atherosclerotic cardiovascular disease; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; and SBP, systolic blood pressure.
To convert total cholesterol and HDL-C to mmol/L, multiply by 0.0259. External validation was conducted to evaluate 10year ASCVD risk prediction in China MUCA (1992-1994) and 5-year ASCVD risk prediction in CIMIC. The baseline characteristics and ASCVD event rates of the 2 validation cohorts are shown in Tables III and IV in the online-only Data Supplement. As shown in Table 4 , compared with the Kaplan-Meier-adjusted events, a slight overprediction of ASCVD events was found in the 2 external validation cohorts. All C statistics in the validation were similar to those from the derivation cohort. Calibration χ 2 values in China MUCA (1992-1994) were 31.7 and 28.2 for men and women, respectively. Both calibration charts across 4 specific predicted risk categories ( Figure 1A ) and calibration plots (Figure 2A and 2B) indicated that no substantial differences existed between the observed rate and the predicted rate in China MUCA (1992) (1993) (1994) . Although the calibration χ 2 for the CIMIC cohort was much higher than 20 (χ 2 =81.3 for men and χ 2 =123.5 for women) in an extremely large sample size with a total of 70 838 subjects, the calibration charts and plots illustrated good agreement between the observations and the predictions (Figures 1B, 2C, and 2D) .
Compared with our equations, the PCEs had lower C statistics and much higher calibration χ 2 values for men and women across most of the cohorts, whereas calibrations in the PCEs for women seemed better as the PCEs were applied to China MUCA (1992-1994) ( Table 4 ). Generally speaking, our China-PAR equations were powerful in discrimination and had a better model fit than the PCEs. Furthermore, the PCEs for white Americans overestimated risk for Chinese men and underestimated risk for Chinese women. For example, in our China MUCA (1992-1994) validation cohort, the observed ASCVD events within the 10-year period in men were 218.7 adjusted by the Kaplan-Meier method. Our China-PAR equations overpredicted events by only 17% with estimated events of 255.9, but the PCEs for white Americans overpredicted by 54% with 336.9 estimated events in men. In addition, we found that the PCEs for blacks overestimated risk for both Chinese men and women ( Table 4 
and Figures II-IV in the online-only Data Supplement).
Recalibration analysis of PCEs was conducted in the current derivation cohort. In the recalibrated PCE functions, the coefficients were taken from the PCEs, but mean values from the Chinese derivation cohort were used for the risk factors and mean incidence rates. Recalibration did not affect the discriminatory ability according to the C statistic. In addition, the recalibration of PCEs overestimated ASCVD events much more and had higher calibration χ 2 than the current Chinese equations, as shown in Table V in the online-only Data Supplement, which suggested that the recalibrated prediction equations did not improve the calibration substantially.
DiscussiOn
The China-PAR project developed and validated the first equations for 10-year ASCVD risk prediction in a Chinese population from 4 large, contemporary, population-based Chinese cohorts. The sex-specific China-PAR equations had excellent performance of ASCVD risk prediction with good internal consistency and external validation. Our results also demonstrated that the PCEs in the American College of Cardiology/American Heart Association guideline were not appropriate for the Chinese population.
Estimation of absolute risk of CVD commonly relies on prediction models derived from prospective cohort studies. Liu et al 14 the Framingham CHD Risk Assessment Tool. Wu et al 15 developed 10-year risk prediction models for ischemic CVD, including ischemic stroke and coronary events, using derivation and validation cohorts with 9903 and 17 329 subjects, respectively. However, both of these prediction models were derived at least 10 years ago. The epidemics of CVD and risk factors have changed during the past decade. The risk prediction equations developed from recent data will generalize better to contemporary populations and identify high-risk individuals with appropriately predicted risk probability. Furthermore, the previous Chinese equations as mentioned above could not evaluate ASCVD outcome. The current
China-PAR equations are focused on risk prediction of ASCVD events, were developed from the most recent cohorts with a high follow-up rate of 90.1% among 21 320 Chinese participants, and were validated by 2 independent cohorts with 14 123 and 70 838 participants. In addition, the adjudication for outcomes with a standardized review process using the same diagnosis criteria across cohorts further strengthened the present investigation.
Several key risk factors have been established to account for ASCVD risk and were conjointly used to devise multivariable risk prediction tools previously. 10, 14, 15, 28 Thus, our equations directly included age, SBP, total cholesterol, HDL-C, current smoking, and diabetes mel- litus. Four additional covariates (WC, geographic region, urbanization, and family history of ASCVD) met the predefined inclusion criteria based on relative IDI (≥6%), whereas they were not included in Chinese prediction models previously. 14, 15 These 4 factors were incorporated to improve the discrimination ability of our equations. Some studies supported WC as a better predictor for CVD than body mass index, 29, 30 and in our equations, WC had a higher relative IDI than body mass index in both men (6.9% versus 3.2%) and women (9.6% versus 9.2%). Although risk of obesity appeared to be mediated via total cholesterol, HDL-C, hypertension, and diabetes mellitus, the association of WC with ASCVD risk was still significant after controlling for these other factors in our populations. This suggested that central obesity deserves more attention in the primary prevention of ASCVD among Chinese adults. In addition, considering residential differences in profiles of CVD burden and risk factors, 3, 31 the variables of geographic region and urbanization further improved the prediction capability and the generalizability of our equations. Furthermore, ASCVD events yielded familial aggregation possibly as a result of genetic determinants of risk factors or shared environmental factors. 32 Both the QRISK and ASSIGN (Assessing Cardiovascular Risk Using SIGN Guidelines to Assign Preventive Treatment) scores incorporated the variable of family history to predict CVD events in Europeans because of better calibrations. 9, 33 Likewise, family history was ascertained in our cohorts, and adding the information enhanced the prediction usefulness of our equations for Chinese. Compared with established risk prediction tools such as the Framingham general CVD equations, 7 the PCEs reported in the 2013 American College of Cardiology/ American Heart Association guideline obtained good discrimination and calibration with internal validation by 10×10 cross-validation and external validation among Americans. 10, 34 However, it did not work well when applied to East Asian populations. 28, 35 Similar results were found in our analysis. For example, compared with the PCEs for white Americans, the China-PAR equations had a lower calibration χ 2 in men (31.7 versus 118.8) when applied to our external validation cohort, China MUCA (1992-1994) ( Table 4 ). Our equations predicted an AS-CVD risk of 11.0% for a man and 10.1% for a woman with the baseline characteristics shown in Table I but decrease to 6.7% for the woman using the PCEs for white Americans (data not shown). The substantial differences in prediction capability between the PCEs and the China-PAR equations might be explained by ethnic heterogeneities, distinct risk profiles of CVD burden, and different treatment and control rates for risk factors (eg, hypertension, hyperlipidemia, and diabetes mellitus). [36] [37] [38] [39] [40] [41] Our project provided sex-specific equations for 10year ASCVD risk estimation in China, and prediction of ASCVD risk made it easy to match the probability of AS-CVD reducing with the intensity of risk factor lowering. In addition, multivariable risk assessment took seriously high-risk ASCVD candidates with clustering of multiple marginal risk factors and avoided unnecessary warnings to individuals a sole isolated risk factor. However, it should be highlighted that risk score per se cannot be converted into better outcomes for patients or declines in ASCVD unless it can be used appropriately by physicians and understood by high-risk individuals. In the future, training among physicians is required to commu-nicate predicted 10-year risk of ASCVD to patients appropriately when the equations are applied in prevention practice.
Several limitations in our modeling should be addressed. First, the outcome events in the present research encompass only hard end points of ASCVD, whereas some atherosclerosis-related events such as angina pectoris and intermittent claudication were not included. The predicted absolute risks of these events could not be evaluated by the present equations. Thus, caution should be used when the equations are applied in practice. Second, information about lipid-lowering treatment was not collected in the China MUCA (1998), and it was not considered in our equations. However, the lipidlowering treatment rate in China was only 3.4% in 2000 and 5.1% in 2008. 40, 42 Thus, overlooking lipid-lowering treatment in the algorithm should have no substantial impact on our equations. Third, although the China-PAR equations were well validated in China MUCA (1992-1994), our equations overestimated ASCVD events with high calibration χ 2 in the CIMIC cohort that had a large sample size of 70 838 participants with 5.9 years of follow-up. However, the statistical test for calibration χ 2 was sensitive to sample size, 24 and testing should be accompanied by assessment of calibration plots, which showed good agreement in the CIMIC cohort ( Figure 2C and 2D). The findings were tolerable for the external validation. Further investigation is warranted to examine whether the 10-year risk prediction equations could have good performance in other large-scale cohorts with short durations of follow-up. The China-PAR equations focused on estimating risk of ASCVD developed within a 10-year period. Lifetime risk evaluation should otherwise be considered when individuals are classified as having a low absolute 10-year risk.
cOnclusiOns
The China-PAR project developed equations with good ability to predict 10-year ASCVD risk among Chinese population. Applying this tool will help to identify highrisk individuals and match the intensity of preventive interventions to an individual's absolute risk of ASCVD development. It will be important in the practice of AS-CVD management in China. The risk prediction equations provide a valuable tool to quantify risk and to guide individualized primary care among Chinese populations.
More aggressive risk factor modification should be required among individuals with a predicted high risk. In addition, serial ASCVD risk assessments will be beneficial to monitor the improvement in control of risk factors at individual level. Further studies are warranted to link the ASCVD risk prediction to goals of therapy for risk factors in future guidelines for ASCVD prevention and management in China.
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